Vaccinex Analysis

Vaccinex is undervalued with Real Value of 0.0 and Hype Value of 0.0. The main objective of Vaccinex pink sheet analysis is to determine its intrinsic value, which is an estimate of what Vaccinex is worth, separate from its market price. There are two main types of Vaccinex's stock analysis: fundamental analysis and technical analysis.
The Vaccinex pink sheet is traded in the USA on PINK Exchange, with the market opening at 09:30:00 and closing at 16:00:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in the USA.
  
Check out World Market Map to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.

Vaccinex Pink Sheet Analysis Notes

About 51.0% of the company outstanding shares are owned by institutional investors. The company recorded earning per share (EPS) of 7.42. Vaccinex had not issued any dividends in recent years. The entity had 1:14 split on the 20th of February 2024. Vaccinex, Inc., a clinical-stage biotechnology company, focuses on treating cancer and neurodegenerative disease through the inhibition of semaphorin 4D . Vaccinex, Inc. was incorporated in 2001 and is headquartered in Rochester, New York. Vaccinex operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs people.The quote for Vaccinex is published daily by the National Quotation Bureau and the company does not need to meet minimum requirements or file with the SEC. For more information please call Maurice Zauderer at 585 271 2700 or visit https://www.vaccinex.com.

Vaccinex Investment Alerts

Vaccinex is not yet fully synchronised with the market data
Vaccinex has some characteristics of a very speculative penny stock
Vaccinex has a very high chance of going through financial distress in the upcoming years
The company reported the previous year's revenue of 570 K. Net Loss for the year was (20.25 M) with loss before overhead, payroll, taxes, and interest of (13.7 M).
Vaccinex currently holds about 11.4 M in cash with (17.23 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.27.

Vaccinex Upcoming and Recent Events

Earnings reports are used by Vaccinex to provide an update of all three financial statements, including the income statement, the balance sheet, and the cash flow statement. Every quarterly earnings report provides investors with three things: an overview of sales, expenses, and net income for the most recent period..
1st of April 2024
Upcoming Quarterly Report
View
31st of December 2023
Next Fiscal Quarter End
View

Vaccinex Thematic Classifications

In addition to having Vaccinex pink sheet in your portfolios, you can add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your favorite investment opportunity, you can then obtain an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility. If you are a result-oriented investor, you can benefit from optimizing one of our existing themes to build an efficient portfolio against your specific investing outlook.
Pharmaceutical Products Idea
Pharmaceutical Products
USA Equities from Pharmaceutical Products industry as classified by Fama & French

Vaccinex Market Capitalization

The company currently falls under 'Nano-Cap' category with a current market capitalization of 2.86 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Vaccinex's market, we take the total number of its shares issued and multiply it by Vaccinex's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.

Vaccinex Insider Trading Activities

Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Vaccinex insiders, such as employees or executives, is commonly permitted as long as it does not rely on Vaccinex's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Vaccinex insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
 
Maurice Zauderer over six months ago
Acquisition by Maurice Zauderer of 1877 shares of Vaccinex at 8.21 subject to Rule 16b-3
 
Van Strydonck, Gerald E. over six months ago
Disposition of 3149 shares by Van Strydonck, Gerald E. of Vaccinex at 0.72 subject to Rule 16b-3
 
Maurice Zauderer over six months ago
Acquisition by Maurice Zauderer of 46153 shares of Vaccinex at 3.25 subject to Rule 16b-3
 
Elizabeth Evans over six months ago
Acquisition by Elizabeth Evans of 1341 shares of Vaccinex at 8.21 subject to Rule 16b-3
 
Jill Sanchez over six months ago
Disposition of tradable shares by Jill Sanchez of Vaccinex at 615.3 subject to Rule 16b-3
 
Friedberg Albert over six months ago
Acquisition by Friedberg Albert of 6711552 shares of Vaccinex at 0.3743 subject to Rule 16b-3
 
Friedberg Albert over six months ago
Acquisition by Friedberg Albert of 100 shares of Vaccinex at 4.51 subject to Rule 16b-3
 
Friedberg Albert over six months ago
Acquisition by Friedberg Albert of 2753 shares of Vaccinex at 4.92 subject to Rule 16b-3
 
Friedberg Albert over six months ago
Acquisition by Friedberg Albert of 3653 shares of Vaccinex at 4.6 subject to Rule 16b-3
 
Van Strydonck, Gerald E. over six months ago
Acquisition by Van Strydonck, Gerald E. of 2000 shares of Vaccinex at 1.3 subject to Rule 16b-3
 
Friedberg Albert over six months ago
Acquisition by Friedberg Albert of 11703 shares of Vaccinex at 4.72 subject to Rule 16b-3
 
Yanni Barbara over six months ago
Acquisition by Yanni Barbara of 53254 shares of Vaccinex at 1.12 subject to Rule 16b-3

Vaccinex Outstanding Bonds

Vaccinex issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Vaccinex uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Vaccinex bonds can be classified according to their maturity, which is the date when Vaccinex has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.

Be your own money manager

As an investor, your ultimate goal is to build wealth. Optimizing your investment portfolio is an essential element in this goal. Using our pink sheet analysis tools, you can find out how much better you can do when adding Vaccinex to your portfolios without increasing risk or reducing expected return.

Did you try this?

Run Economic Indicators Now

   

Economic Indicators

Top statistical indicators that provide insights into how an economy is performing
All  Next Launch Module
Check out World Market Map to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.
You can also try the Financial Widgets module to easily integrated Macroaxis content with over 30 different plug-and-play financial widgets.

Other Consideration for investing in Vaccinex Pink Sheet

If you are still planning to invest in Vaccinex check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Vaccinex's history and understand the potential risks before investing.
Portfolio Center
All portfolio management and optimization tools to improve performance of your portfolios
Pattern Recognition
Use different Pattern Recognition models to time the market across multiple global exchanges
Investing Opportunities
Build portfolios using our predefined set of ideas and optimize them against your investing preferences
Commodity Channel
Use Commodity Channel Index to analyze current equity momentum
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
Piotroski F Score
Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals
Global Markets Map
Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes
Economic Indicators
Top statistical indicators that provide insights into how an economy is performing
Top Crypto Exchanges
Search and analyze digital assets across top global cryptocurrency exchanges